Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II trial of interleukin-2 in myelodysplastic syndromes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II trial of interleukin-2 in myelodysplastic syndromes.
A phase II trial of interleukin-2 in myelodysplastic syndromes. Br J Haematol. 1998 Apr; 101(1):205-7.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
CD56 Antigen
Female
Humans
Interleukin-2
Killer Cells, Natural
Lymphocyte Count
Male
Middle Aged
Myelodysplastic Syndromes
Receptors, IgG
authors with profiles
Wendy Stock